Mikhail Geyfman, Ph.D., is a Principal Scientist I at Allergan Aesthetics, an AbbVie Company, where they focus on discovering novel therapies for dermatological and aesthetic conditions. Mikhail has extensive experience in the biopharmaceutical industry, previously working as a Research Scientist at KYTHERA Biopharmaceuticals and holding various roles at Allergan since 2015. They earned a Ph.D. from UC Irvine, where their research centered on the circadian clock's role in skin biology. Mikhail also contributed to the field as a reviewer for the Journal of Experimental Dermatology and conducted postdoctoral research at the Gavin Herbert Eye Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices